With a national footprint in 5 states, MariMed (MRMD) has had 11 consecutive quarters of revenue growth and positive EBITDA growth in 6 of the past 7 quarters. Looking at strategic growth and focused on consolidation and expansion, MariMed offers a full range of cannabis products. CEO Bob Fireman joined us to provide insights on the company.
00:48 MariMed’s growth (Revenue and EBITDA)
02:46 Massachusetts Operations
04:12 Region with the most Potential
05:49 Number of States to Operate In
07:00 Plans for Cash
08:52 Managed Client Based Businesses
10:42 Organic Growth
11:52 Product Formats and Long-Term Growth
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.